References

The OncoLife™ Survivorship Care Plan editorial team utilizes many references from medical literature to create the content within the care plan. The following is a list of references used to create the program.

The Children’s Oncology Group. Long-Term Follow-Up Guidelines for Survivors of Childhood, Adolescent, and Young Adult Cancers. Version 5.0, October 2018. http://www.survivorshipguidelines.org/

The National Comprehensive Cancer Network Guidelines

National Osteoporosis Foundation

US Preventive Task Force

Feuerstein, M., & Nekhlyudov, L. (2018). Handbook of Cancer Survivorship, 2^nd. Ed. Springer, https://doi.org/10.1007/978-3-319-77432

Medical Oncology References

Alemán, J. O., Farooki, A., & Girotra, M. (2014). Effects of tyrosine kinase inhibition on bone metabolism: untargeted consequences of targeted therapies. Endocrine-Related Cancer, 21(3), R247–R259. https://doi.org/10.1530/ERC-12-0400

Amidi, A., Christensen, S., Mehlsen, M., Jensen, A. B., Pedersen, A. D., & Zachariae, R. (2015). Long-term subjective cognitive functioning following adjuvant systemic treatment: 7–9 years follow-up of a nationwide cohort of women treated for primary breast cancer. British Journal of Cancer, 113(5), 794–801. https://doi.org/10.1038/bjc.2015.243

Armenian, S. H., Lacchetti, C., Barac, A., Carver, J., Constine, L. S., Denduluri, N., ... & Fabian, C. (2016). Prevention and monitoring of cardiac dysfunction in survivors of adult cancers: American Society of Clinical Oncology Clinical Practice Guideline. Journal of Clinical Oncology,35(8), 893-911.

Beech, J., Germetaki, T., Judge, M., Paton, N., Collins, J., Garbutt, A., … Saunders, M. P. (2018). Management and grading of EGFR inhibitor-induced cutaneous toxicity. Future Oncology, 14(24), 2531–2541. https://doi.org/10.2217/fon-2018-0187

Berman, E., Girotra, M., Cheng, C., Chanel, S., Maki, R., Shelat, M., … Farooki, A. (2013). Effect of long term imatinib on bone in adults with chronic myelogenous leukemia and gastrointestinal stromal tumors. Leukemia Research, 37(7), 790–794. https://doi.org/10.1016/j.leukres.2013.02.005

Boer, H., Proost, J. H., Nuver, J., Bunskoek, S., Gietema, J. Q., Geubels, B. M., … Gietema, J. A. (2015). Long-term exposure to circulating platinum is associated with late effects of treatment in testicular cancer survivors. Annals of Oncology, 26(11), 2305–2310. https://doi.org/10.1093/annonc/mdv369

Bray, V. J., Dhillon, H. M., & Vardy, J. L. (2018). Systematic review of self-reported cognitive function in cancer patients following chemotherapy treatment. Journal of Cancer Survivorship, 12(4), 537–559. https://doi.org/10.1007/s11764-018-0692-x

Brewster, K. K., Shalev, D., & Levenson, J. A. (2017). Chemotherapy-Related Cognitive Impairment #342. Journal of Palliative Medicine, 20(12), 1407–1408. https://doi.org/10.1089/jpm.2017.0524

Caldemeyer, L., Dugan, M., Edwards, J., & Akard, L. (2016). Long-Term Side Effects of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia. Current Hematologic Malignancy Reports, 11(2), 71–79. https://doi.org/10.1007/s11899-016-0309-2

Cameron, D. A., Douglas, S., Brown, J. E., & Anderson, R. A. (2010). Bone mineral density loss during adjuvant chemotherapy in pre-menopausal women with early breast cancer: is it dependent on oestrogen deficiency? Breast Cancer Research and Treatment, 123(3), 805–814. https://doi.org/10.1007/s10549-010-0899-7

Cardinale, D., Colombo, A., Bacchiani, G., Tedeschi, I., Meroni, C. A., Veglia, F., … Cipolla, C. M. (2015). Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy. Circulation, 131(22), 1981–1988. https://doi.org/10.1161/CIRCULATIONAHA.114.013777

Carver, J. R., Shapiro, C. L., Ng, A., Jacobs, L., Schwartz, C., Virgo, K. S., … Vaughn, D. J. (2007). American Society of Clinical Oncology Clinical Evidence Review on the Ongoing Care of Adult Cancer Survivors: Cardiac and Pulmonary Late Effects. Journal of Clinical Oncology, 25(25), 3991–4008. https://doi.org/10.1200/JCO.2007.10.9777

Children’s Oncology Group. (2019). Long-Term Follow-Up Guidelines for Survivors of Childhood, Adolescent, and Young Adult Cancers.Retrieved January 28, 2019, from http://www.survivorshipguidelines.org/

Chu, C.-Y., Choi, J., Eaby-Sandy, B., Langer, C. J., & Lacouture, M. E. (2018). Osimertinib: A Novel Dermatologic Adverse Event Profile in Patients with Lung Cancer. The Oncologist, 23(8), 891–899. https://doi.org/10.1634/theoncologist.2017-0582

Cochran, T. R., Franco, V. I., Scully, R., & Lipshultz, S. E. (2017). Anthracycline, Trastuzumab, and Cardiovascular Toxicity. Cardiovascular Toxicology, 432–446. https://doi.org/10.1016/B978-0-12-801238-3.95641-1

Damodaran, S., Bellavia, T., Sait, S. N., Wang, E. S., Wetzler, M., & Khushalani, N. I. (2012). Acute myeloid leukemia secondary to oxaliplatin treatment for esophageal cancer. Clinical Colorectal Cancer, 11(2), 151-154.

Di Bisceglie, A. M., Lok, A. S., Martin, P., Terrault, N., Perrillo, R. P., & Hoofnagle, J. H. (2015). Recent US Food and Drug Administration Warnings on Hepatitis B Reactivation With Immune-Suppressing and Anticancer Drugs: Just the Tip of the Iceberg? Hepatology (Baltimore, Md.), 61(2), 703–711. https://doi.org/10.1002/hep.27609

Driessen, C., Snik, A., Leijendeckers, J., de Boer, J. P., Gelderblom, H., van Opstal, C., … van Herpen, C. (2016). Ototoxicity in locally advanced head and neck cancer (LAHNC) patients (pts) treated with induction chemotherapy (IC) followed by cisplatin-based chemoradiotherapy (CRT). Annals of Oncology, 27(suppl_6). https://doi.org/10.1093/annonc/mdw376.41

Eaby-Sandy, B. (2017) Where are we with TKI Toxicities. Journal of Thoracic Oncology, 12(1), S205–S206. https://doi.org/10.1016/j.jtho.2016.11.183

Eaby-Sandy, B. (2017). MS 10.05 Immunotherapy: The Latest. https://doi.org/10.1016/j.jtho.2017.09.237

Ezoe, S. (2012). Secondary Leukemia Associated with the Anti-Cancer Agent, Etoposide, a Topoisomerase II Inhibitor. International Journal of Environmental Research and Public Health, 9(7), 2444–2453. https://doi.org/10.3390/ijerph9072444

Gallicchio, L., Calhoun, C., & Helzlsouer, K. (2016). Aromatase inhibitor-related side effects and associated treatment discontinuation. Journal of Clinical Oncology, 34(15_suppl), 10076–10076. https://doi.org/10.1200/JCO.2016.34.15_suppl.10076

Gallicchio, L., Calhoun, C., & Helzlsouer, K. (2017, September 1). A prospective study of aromatase inhibitor therapy initiation and self-reported side effects. https://doi.org/10.1007/s00520-017-3678-8

Godley, L., Larsen, R. (2008). Therapy-Related Myeloid Leukemia. Seminars in Oncology, 35(4), 418–429.

Gralow, J. R., Biermann, J. S., Farooki, A., Fornier, M. N., Gagel, R. F., Kumar, R. N., … Poznak, C. H. V. (2009). NCCN Task Force Report: Bone Health in Cancer Care. Journal of the National Comprehensive Cancer Network, 7(Suppl 3), S-1-S-32. https://doi.org/10.6004/jnccn.2009.0076

Grandin, E. W., Ky, B., Cornell, R. F., Carver, J., & Lenihan, D. J. (2015). Patterns of cardiac toxicity associated with irreversible proteasome inhibition in the treatment of multiple myeloma. Journal of Cardiac Failure, 21(2), 138-144.

Grever, M. R., Abdel-Wahab, O., Andritsos, L. A., Banerji, V., Barrientos, J., Blachly, J. S., … Falini, B. (2017). Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia. Blood, 129(5), 553–560. https://doi.org/10.1182/blood-2016-01-689422

Handforth, C., D’Oronzo, S., Coleman, R., & Brown, J. (2018). Cancer Treatment and Bone Health. Calcified Tissue International, 102(2), 251–264.

Harris, C., & Sander, C. R. (2017). Late respiratory effects of cancer treatment: Current Opinion in Supportive and Palliative Care, 11(3), 197–204. https://doi.org/10.1097/SPC.0000000000000286

Hartmann, J. T., Haap, M., Kopp, H.-G., & Lipp, H.-P. (2009). Tyrosine Kinase Inhibitors - A Review on Pharmacology, Metabolism and Side Effects [Text]. https://doi.org/info:doi/10.2174/138920009788897975

Haugnes, H. S., Oldenburg, J., & Bremnes, R. M. (2015, September). Pulmonary and cardiovascular toxicity in long-term testicular cancer survivors. In Urologic Oncology: Seminars and Original Investigations (Vol. 33, No. 9, pp. 399-406). Elsevier.

Haugnes, H. S., Stenklev, N. C., Brydøy, M., Dahl, O., Wilsgaard, T., Laukli, E., & Fosså, S. D. (2018). Hearing loss before and after cisplatin-based chemotherapy in testicular cancer survivors: a longitudinal study. Acta Oncologica, 57(8), 1075–1083. https://doi.org/10.1080/0284186X.2018.1433323

Hess, L. M., Huang, H. Q., Hanlon, A. L., Robinson, W. R., Johnson, R., Chambers, S. K., ... & Lele, S. (2015). Cognitive function during and six months following chemotherapy for front-line treatment of ovarian, primary peritoneal or fallopian tube cancer: an NRG oncology/gynecologic oncology group study. Gynecologic oncology, 139(3), 541-545. https://doi.org/10.1016/j.ijporl.2018.01.028

Janelsins, M. C., Heckler, C. E., Peppone, L. J., Kamen, C., Mustian, K. M., Mohile, S. G., … Morrow, G. R. (2016). Cognitive Complaints in Survivors of Breast Cancer After Chemotherapy Compared With Age-Matched Controls: An Analysis From a Nationwide, Multicenter, Prospective Longitudinal Study. Journal of Clinical Oncology, 35(5), 506–514. https://doi.org/10.1200/JCO.2016.68.5826

Kang, Y., Assuncao, B. L., Denduluri, S., McCurdy, S., Luger, S., Lefebvre, B., ... & Scherrer-Crosbie, M. (2019). Symptomatic heart failure in acute leukemia patients treated with anthracyclines. JACC: CardioOncology, 1(2), 208-217.

Kesler, S., Hosseini, S. H., Heckler, C., Janelsins, M., Palesh, O., Mustian, K., & Morrow, G. (2013). Cognitive training for improving executive function in chemotherapy-treated breast cancer survivors. Clinical breast cancer, 13(4), 299-306.

Landier, W. (2016). Ototoxicity and cancer therapy. Cancer, 122(11), 1647–1658. https://doi.org/10.1002/cncr.29779

Latcha, S., Jaimes, E. A., Patil, S., Glezerman, I. G., Mehta, S., & Flombaum, C. D. (2016). Long–Term Renal Outcomes after Cisplatin Treatment. Clinical Journal of the American Society of Nephrology, 11(7), 1173–1179. https://doi.org/10.2215/CJN.08070715

Leger, P., Limper, A. H., & Maldonado, F. (2017). Pulmonary toxicities from conventional chemotherapy. Clinics in Chest Medicine, 38(2), 209-222.

Mikhael, J. (2016). Management of carfilzomib-associated cardiac adverse events. Clinical Lymphoma Myeloma and Leukemia, 16(5), 241-245.

Morton, L. M., Dores, G. M., Schonfeld, S. J., Linet, M. S., Sigel, B. S., Lam, C. J. K., … Curtis, R. E. (2018). Association of Chemotherapy for Solid Tumors With Development of Therapy-Related Myelodysplastic Syndrome or Acute Myeloid Leukemia in the Modern Era. JAMA Oncology. https://doi.org/10.1001/jamaoncol.2018.5625

Moslehi, J. J. (2016). Cardiovascular toxic effects of targeted cancer therapies. New England Journal of Medicine, 375(15), 1457-1467.

Nasioudis, D., Lontos, K., Tsagianni, A., Boyiadzis, M., & Ko, E. M. (2018). Acute Myeloid Leukemia Following Gynecologic Cancer in the Era of Platinum-Based Chemotherapy: International Journal of Gynecological Cancer, 28(8), 1639–1642. https://doi.org/10.1097/IGC.0000000000001338

National Comprehensive Cancer Network (2019). NCCN Clinical Practice Guidelines in Oncology:Survivorship. Retrieved from: https://www.nccn.org/professionals/physician_gls/pdf/survivorship.pdf (registration required)

National Osteoporosis Foundation website: https://www.nof.org/, retrieved Jan. 2019.

Nyrop, K. A., Callahan, L. F., Rini, C., Altpeter, M., Hackney, B., DePue, A., … Muss, H. B. (2016, June 1). Aromatase inhibitor associated arthralgia: the importance of oncology provider-patient communication about side effects and potential management through physical activity. https://doi.org/10.1007/s00520-015-3065-2

Olson, K., Hewit, J., Slater, L. G., Chambers, T., Hicks, D., Farmer, A., … Kolb, B. (2016, July 1). Assessing cognitive function in adults during or following chemotherapy: a scoping review. https://doi.org/10.1007/s00520-016-3215-1

Phillips, S. M., Lloyd, G. R., Awick, E. A., & McAuley, E. (2017). Relationship between self-reported and objectively measured physical activity and subjective memory impairment in breast cancer survivors: role of self-efficacy, fatigue and distress. Psycho-Oncology, 26(9), 1390–1399. https://doi.org/10.1002/pon.4156

Plana, J. C., Galderisi, M., Barac, A., Ewer, M. S., Ky, B., Scherrer-Crosbie, M., … Lancellotti, P. (2014). Expert Consensus for Multimodality Imaging Evaluation of Adult Patients during and after Cancer Therapy: A Report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Journal of the American Society of Echocardiography, 27(9), 911–939. https://doi.org/10.1016/j.echo.2014.07.012

Ramin, C., May, B. J., Roden, R. B. S., Orellana, M. M., Hogan, B. C., McCullough, M. S., … Visvanathan, K. (2018). Evaluation of osteopenia and osteoporosis in younger breast cancer survivors compared with cancer-free women: a prospective cohort study. Breast Cancer Research, 20(1), 134. https://doi.org/10.1186/s13058-018-1061-4

Sanford, N. N., Miao, R., Wang, H., Goldberg, S., Jacobson, A., Brunner, A. M., ... & Jee, K. W. (2019). Characteristics and Predictors for Secondary Leukemia and Myelodysplastic Syndrome in Ewing and Osteosarcoma Survivors. International Journal of Radiation Oncology* Biology* Physics, 103(1), 52-61.

Schwartz, C. L., Hobbie, W. L., Constine, L. S., & Ruccione, K. S. (Eds.). (2015). Survivors of Childhood and Adolescent Cancer. https://doi.org/10.1007/978-3-319-16435-9

Stava, C., Beck, M., & Vassilopoulou-Sellin, R. (2005). Cataracts among cancer survivors. American journal of clinical oncology, 28(6), 603-608.

Stouten-Kemperman, M. M., de Ruiter, M. B., Caan, M. W. A., Boogerd, W., Kerst, M. J., Reneman, L., & Schagen, S. B. (2015). Lower cognitive performance and white matter changes in testicular cancer survivors 10 years after chemotherapy. Human Brain Mapping, 36(11), 4638–4647. https://doi.org/10.1002/hbm.22942

Thanopoulou, E., & Judson, I. (2012). The safety profile of imatinib in CML and GIST: long-term considerations. Archives of Toxicology, 86(1), 1–12. https://doi.org/10.1007/s00204-011-0729-7

Tromp, J., Steggink, L. C., Veldhuisen, D. V., Gietema, J. A., & Meer, P. van der. (2017a). Cardio‐Oncology: Progress in Diagnosis and Treatment of Cardiac Dysfunction. Clinical Pharmacology & Therapeutics, 101(4), 481–490. https://doi.org/10.1002/cpt.614

Versluys, A.B., Bresters, D. (2016). Pulmonary Complications of Childhood Cancer Treatment. (2016). Paediatric Respiratory Reviews, 17, 63–70.

Vitali, M., Ripamonti, C. I., Roila, F., Proto, C., Signorelli, D., Imbimbo, M., ... & Garassino, M. C. (2017). Cognitive impairment and chemotherapy: a brief overview. Critical reviews in oncology/hematology, 118, 7-14.

Waissbluth, S., Chuang, A., Del Valle, Á., & Cordova, M. (2018). Long term platinum-induced ototoxicity in pediatric patients. International journal of pediatric otorhinolaryngology, 107, 75-79.

Waissbluth, S., Peleva, E., & Daniel, S. J. (2017). Platinum-induced ototoxicity: a review of prevailing ototoxicity criteria. European Archives of Oto-Rhino-Laryngology, 274(3), 1187–1196. https://doi.org/10.1007/s00405-016-4117-z

Whitlock, J. A., Greer, J. P., & Lukens, J. N. (1991a). Epipodophyllotoxin-related leukemia. Identification of a new subset of secondary leukemia. Cancer, 68(3), 600–604. https://doi.org/10.1002/1097-0142(19910801)68:3<600::AID-CNCR2820680326>3.0.CO;2-F

Yilmaz, N., Emmungil, H., Gucenmez, S., Ozen, G., Yildiz, F., Balkarli, A., … Yavuz, S. (2015). Incidence of Cyclophosphamide-induced Urotoxicity and Protective Effect of Mesna in Rheumatic Diseases. The Journal of Rheumatology, 42(9), 1661–1666. https://doi.org/10.3899/jrheum.150065

Zimmer, P., Mierau, A., Bloch, W., Strüder, H. K., Hülsdünker, T., Schenk, A., … Elter, T. (2015). Post-chemotherapy cognitive impairment in patients with B-cell non-Hodgkin lymphoma: a first comprehensive approach to determine cognitive impairments after treatment with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone or rituximab and bendamustine. Leukemia & Lymphoma, 56(2), 347–352. https://doi.org/10.3109/10428194.2014.915546

Radiation Therapy References

Agarwalla, A., Small, A. J., Mendelson, A. H., Scott, F. I., & Kochman, M. L. (2015). Risk of recurrent or refractory strictures and outcome of endoscopic dilation for radiation-induced esophageal strictures. Surgical Endoscopy, 29(7), 1903–1912. https://doi.org/10.1007/s00464-014-3883-1

Archer, E. L., Liao, E. A., & Trobe, J. D. (2018). Radiation-Induced Optic Neuropathy: Clinical and Imaging Profile of Twelve Patients. Journal of Neuro-Ophthalmology: The Official Journal of the North American Neuro-Ophthalmology Society. https://doi.org/10.1097/WNO.0000000000000670

Baradaran-Ghahfarokhi, M. (2012). Radiation-induced kidney injury. Journal of Renal Injury Prevention, 1(2), 49–50. https://doi.org/10.12861/jrip.2012.17

Beukema, J. C., van Luijk, P., Widder, J., Langendijk, J. A., & Muijs, C. T. (2015). Is cardiac toxicity a relevant issue in the radiation treatment of esophageal cancer? Radiotherapy and Oncology, 114(1), 85–90. https://doi.org/10.1016/j.radonc.2014.11.037

Boerma, M., Sridharan, V., Mao, X.-W., Nelson, G. A., Cheema, A. K., Koturbash, I., … Hauer-Jensen, M. (2016). Effects of ionizing radiation on the heart. Mutation Research/Reviews in Mutation Research, 770, 319–327. https://doi.org/10.1016/j.mrrev.2016.07.003

Browne, C., Davis, N. F., Mac Craith, E., Lennon, G. M., Mulvin, D. W., Quinlan, D. M., … Galvin, D. J. (2015). A Narrative Review on the Pathophysiology and Management for Radiation Cystitis [Research article]. https://doi.org/10.1155/2015/346812

Buschbacher, R. M. (2010). Rehabilitation Medicine Quick Reference. Spine, 66-67.

Celii, F. G., & Beckmann, N. M. (2019). Radiation-induced insufficiency fracture of the femur 18 years after radiation therapy. Radiology case reports, 14(2), 179-183.

Children’s Oncology Group. (2018). Colorectal cancer: are you at risk? Retrieved 27 June 2019 from: http://www.survivorshipguidelines.org/pdf/2018/English%20Health%20Links/10_colorectal_cancer%20(secured).pdf

Conway, J. L., Connors, J. M., Tyldesley, S., Savage, K. J., Campbell, B. A., Zheng, Y. Y., ... & Pickles, T. (2017). Secondary breast cancer risk by radiation volume in women with Hodgkin lymphoma. International Journal of Radiation Oncology* Biology* Physics, 97(1), 35-41.

Daly, P. E., Samiee, S., Cino, M., Gryfe, R., Pollett, A., Ng, A., … Hodgson, D. C. (2017). High prevalence of adenomatous colorectal polyps in young cancer survivors treated with abdominal radiation therapy: Results of a prospective trial. Gut, 66(10), 1797–1801. https://doi.org/10.1136/gutjnl-2016-311501

de Vathaire, F., Haddy, N., Allodji, R. S., Hawkins, M., Guibout, C., El-Fayech, C., … Rubino, C. (2015). Thyroid Radiation Dose and Other Risk Factors of Thyroid Carcinoma Following Childhood Cancer. The Journal of Clinical Endocrinology & Metabolism, 100(11), 4282–4290. https://doi.org/10.1210/jc.2015-1690

Felice, F. D., Marchetti, C., Marampon, F., Cascialli, G., Muzii, L., & Tombolini, V. (2019). Radiation effects on male fertility. Andrology, 7(1), 2–7. https://doi.org/10.1111/andr.12562

Gore, S. K., Plowman, N. P., Dharmasena, A., Verity, D. H., & Rose, G. E. (2018). Corneal complications after orbital radiotherapy for primary epithelial malignancies of the lacrimal gland. British Journal of Ophthalmology, 102(7), 882–884. https://doi.org/10.1136/bjophthalmol-2017-311134

Henderson, T. O., Moskowitz, C. S., Chou, J. F., Bradbury, A. R., Neglia, J. P., Dang, C. T., … Oeffinger, K. C. (2016). Breast Cancer Risk in Childhood Cancer Survivors Without a History of Chest Radiotherapy: A Report From the Childhood Cancer Survivor Study. Journal of Clinical Oncology, 34(9), 910–918. https://doi.org/10.1200/JCO.2015.62.3314

Inskip, P. D., Veiga, L. H. S., Brenner, A. V., Sigurdson, A. J., Ostroumova, E., Chow, E. J., … Lubin, J. H. (2018). Hypothyroidism after Radiation Therapy for Childhood Cancer: A Report from the Childhood Cancer Survivor Study. Radiation Research, 190(2), 117–132. https://doi.org/10.1667/RR14888.1

Jensen, P. T., & Froeding, L. P. (2015). Pelvic radiotherapy and sexual function in women. Translational Andrology and Urology, 4(2), 186–205. https://doi.org/10.3978/j.issn.2223-4683.2015.04.06

Koontz, B. F. (2017). Radiation Therapy Treatment Effects: An Evidence-based Guide to Managing Toxicity. Springer Publishing Company.

Levy, J. M., Tello, T., Giller, R., Wilkening, G., Quinones, R., Keating, A., & Liu, A. K. (2013). Late Effects of Total Body Irradiation and Hematopoietic Stem Cell Transplant in Children Under Three Years of Age. Pediatric Blood & Cancer, 60(4), 700–704. https://doi.org/10.1002/pbc.24252

Lin, X., & DeAngelis, L. M. (2015). Treatment of Brain Metastases. Journal of Clinical Oncology, 33(30), 3475–3484. https://doi.org/10.1200/JCO.2015.60.9503

Lutz, S., Balboni, T., Jones, J., Lo, S., Petit, J., Rich, S. E., … Hahn, C. (2017). Palliative radiation therapy for bone metastases: Update of an ASTRO Evidence-Based Guideline. Practical Radiation Oncology, 7(1), 4–12. https://doi.org/10.1016/j.prro.2016.08.001

Morris, L., Do, V., Chard, J., & Brand, A. H. (2017). Radiation-induced vaginal stenosis: Current perspectives. International Journal of Women’s Health, 9, 273–279. https://doi.org/10.2147/IJWH.S106796

Mujica–Mota, M., Waissbluth, S., & Daniel, S. J. (2013). Characteristics of radiation-induced sensorineural hearing loss in head and neck cancer: A systematic review. Head & Neck, 35(11), 1662–1668. https://doi.org/10.1002/hed.23201

National Comprehensive Cancer Network (2019). Head and Neck Cancers. Retrieved from https://www.nccn.org/professionals/physician_gls/pdf/head-and-neck.pdf

NCCN Guidelines Version 1.2019 Hodgkin Lymphoma (Age greater than 18 yo). (n.d.). Retrieved from https://www.nccn.org/professionals/physician_gls/pdf/hodgkins.pdf

Nimwegen, F. A. van, Ntentas, G., Darby, S. C., Schaapveld, M., Hauptmann, M., Lugtenburg, P. J., … Aleman, B. M. P. (2017). Risk of heart failure in survivors of Hodgkin lymphoma: effects of cardiac exposure to radiation and anthracyclines. Blood, 129(16), 2257-2265.

Oeffinger, K. C., Fontham, E. T. H., Etzioni, R., Herzig, A., Michaelson, J. S., Shih, Y.-C. T., … Wender, R. (2015). Breast Cancer Screening for Women at Average Risk: 2015 Guideline Update From the American Cancer Society. JAMA, 314(15), 1599–1614. https://doi.org/10.1001/jama.2015.12783

Roman, B. R., Goldenberg, D., Givi, B., & The Education Committee of American Head and Neck Society (AHNS). (2016). AHNS Series—Do you know your guidelines? Guideline recommended follow-up and surveillance of head and neck cancer survivors. Head & Neck, 38(2), 168–174. https://doi.org/10.1002/hed.24100

Shaitelman, S. F., Amendola, B., Khan, A., Beriwal, S., Rabinovitch, R., Demanes, D. J., ... & Cuttino, L. (2017). American Brachytherapy Society Task Group Report: Long-term control and toxicity with brachytherapy for localized breast cancer. Brachytherapy, 16(1), 13-21.

Skinner, R., Mulder, R. L., Kremer, L. C., Hudson, M. M., Constine, L. S., Bardi, E., … Green, D. M. (2017). Recommendations for gonadotoxicity surveillance in male childhood, adolescent, and young adult cancer survivors: A report from the International Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCareSurFup Consortium. The Lancet Oncology, 18(2), e75–e90. https://doi.org/10.1016/S1470-2045(17)30026-8

Sroussi, H. Y., Epstein, J. B., Bensadoun, R.-J., Saunders, D. P., Lalla, R. V., Migliorati, C. A., … Zumsteg, Z. S. (2017). Common oral complications of head and neck cancer radiation therapy: Mucositis, infections, saliva change, fibrosis, sensory dysfunctions, dental caries, periodontal disease, and osteoradionecrosis. Cancer Medicine, 6(12), 2918–2931. https://doi.org/10.1002/cam4.1221

Stieg, M. R., Renner, U., Stalla, G. K., & Kopczak, A. (2017). Advances in understanding hypopituitarism. F1000Research, 6. https://doi.org/10.12688/f1000research.9436.1

Stubblefield, M. D. (2017). Clinical evaluation and management of radiation fibrosis syndrome. Physical Medicine and Rehabilitation Clinics, 28(1), 89-100.

Stubblefield, Michael D. (Ed.). (2019). Cancer rehabilitation: Principles and practice (Second edition). New York: Springer Publishing Company

Stubblefield, Michael Dean. (2017). Neuromuscular complications of radiation therapy. Muscle & Nerve, 56(6), 1031–1040. https://doi.org/10.1002/mus.25778

Taunk, N. K., Haffty, B. G., Kostis, J. B., & Goyal, S. (2015). Radiation-Induced Heart Disease: Pathologic Abnormalities and Putative Mechanisms. Frontiers in Oncology, 5. https://doi.org/10.3389/fonc.2015.00039

Teepen, J. C., Kok, J. L., van Leeuwen, F. E., Tissing, W. J. E., Dolsma, W. V., van der Pal, H. J., … Zsíros, J. (2018). Colorectal Adenomas and Cancers After Childhood Cancer Treatment: A DCOG-LATER Record Linkage Study. JNCI: Journal of the National Cancer Institute, 110(7), 758–767. https://doi.org/10.1093/jnci/djx266

Thomas, O., Mahé, M.-A., Campion, L., Bourdin, S., Milpied, N., Brunet, G., … Cuillière, J.-C. (2001). Long-term complications of total body irradiation in adults. International Journal of Radiation Oncology • Biology • Physics, 49(1), 125–131. https://doi.org/10.1016/S0360-3016(00)01373-0

Tobin, M. K., Geraghty, J. R., Engelhard, H. H., Linninger, A. A., & Mehta, A. I. (2015). Intramedullary spinal cord tumors: A review of current and future treatment strategies. Neurosurgical Focus, 39(2), E14. https://doi.org/10.3171/2015.5.FOCUS15158

Wei, J., Meng, L., Hou, X., Qu, C., Wang, B., Xin, Y., & Jiang, X. (2018). Radiation-induced skin reactions: Mechanism and treatment. Cancer Management and Research, 11, 167–177. https://doi.org/10.2147/CMAR.S188655

Whelan, R. J., Saccomano, B., King, R., Dorris, K., Hemenway, M., Hankinson, T. C., & Liu, A. K. (2018, May 1). Radiation-induced Cataracts in Children With Brain Tumors Receiving Craniospinal Irradiation [Text]. https://doi.org/info:doi/10.1097/MPH.0000000000001142

White, I. D. (2015). Sexual Difficulties after Pelvic Radiotherapy: Improving Clinical Management. Clinical Oncology, 27(11), 647–655. https://doi.org/10.1016/j.clon.2015.06.018

Wright, J. D., Clair, C. M. S., Deutsch, I., Burke, W. M., Gorrochurn, P., Sun, X., & Herzog, T. J. (2010). Pelvic radiotherapy and the risk of secondary leukemia and multiple myeloma.

Cancer, 116(10), 2486–2492. https://doi.org/10.1002/cncr.25067

Yusuf, S. W., Venkatesulu, B. P., Mahadevan, L. S., & Krishnan, S. (2017). Radiation-Induced Cardiovascular Disease: A Clinical Perspective. Frontiers in Cardiovascular Medicine, 4. https://doi.org/10.3389/fcvm.2017.00066

Zheng, Y., Han, F., Xiao, W., Xiang, Y., Lu, L., Deng, X., … Zhao, C. (2015, January 13). Analysis of late toxicity in nasopharyngeal carcinoma patients treated with intensity modulated radiation therapy. https://doi.org/10.1186/s13014-014-0326-z

Surgery References

American Cancer Society (2019). Surgery for Malignant Mesothelioma. (n.d.). Retrieved February 20, 2019, from https://www.cancer.org/cancer/malignant-mesothelioma/treating/surgery.html

Ashley, D., & Watson, R. (2006). Pretravel Health Advice for Asplenic Individuals. Journal of Travel Medicine, 10(2), 117–121. https://doi.org/10.2310/7060.2003.31772

Bagante, F., Ruzzenente, A., Beal, E. W., Campagnaro, T., Merath, K., Conci, S., … Pawlik, T. M. (2019). Complications after liver surgery: A benchmark analysis. HPB. https://doi.org/10.1016/j.hpb.2018.12.013

Baniel, J., Foster, R. S., Rowland, R. G., Bihrle, R., & Donohue, J. P. (1994). Complications of primary retroperitoneal lymph node dissection. The Journal of urology, 152(2 Part 1), 424-427.

Bendixen, M., Jørgensen, O. D., Kronborg, C., Andersen, C., & Licht, P. B. (2016). Postoperative pain and quality of life after lobectomy via video-assisted thoracoscopic surgery or anterolateral thoracotomy for early stage lung cancer: A randomised controlled trial. The Lancet Oncology, 17(6), 836–844. https://doi.org/10.1016/S1470-2045(16)00173-X

Berti-Hearn, L., & Elliott, B. (2018). A Resource Guide to Improve Nursing Care and Transition to Self-Care for Patients With Ostomies. Home Healthcare Now, 36(1), 43. https://doi.org/10.1097/NHH.0000000000000643

Boutte, H. J., & Rubin, D. C. (2018). Short Bowel Syndrome. In E. Bardan & R. Shaker (Eds.), Gastrointestinal Motility Disorders : A Point of Care Clinical Guide (pp. 343–351). https://doi.org/10.1007/978-3-319-59352-4_31

Brennan, K. E., Hall, S. F., Owen, T. E., Griffiths, R. J., & Peng, Y. (2018). Variation in routine follow-up care after curative treatment for head-and-neck cancer: A population-based study in Ontario. Current Oncology, 25(2), 120–131. https://doi.org/10.3747/co.25.3892

Browning, M. G., Bullen, N., Nokes, T., Tucker, K., & Coleman, M. (2017). The evolving indications for splenectomy. British Journal of Haematology, 177(2), 321–324. https://doi.org/10.1111/bjh.14060

Bulkley, J. E., McMullen, C. K., Grant, M., Wendel, C., Hornbrook, M. C., & Krouse, R. S. (2018). Ongoing ostomy self-care challenges of long-term rectal cancer survivors. Supportive Care in Cancer, 26(11), 3933–3939. https://doi.org/10.1007/s00520-018-4268-0

Buzelé, R., Barbier, L., Sauvanet, A., & Fantin, B. (2016). Medical complications following splenectomy. Journal of Visceral Surgery, 153(4), 277–286. https://doi.org/10.1016/j.jviscsurg.2016.04.013

Cao, S., Jin, S., Cao, J., Shen, J., Zhang, H., Meng, Q., … Yu, Y. (2018). Malignant pericardial mesothelioma : A systematic review of current practice. Herz, 43(1), 61–68. https://doi.org/10.1007/s00059-016-4522-5

Casey, M. J., & Crotzer, D. (2018). Cancer, Endometrial. In StatPearls. Retrieved from http://www.ncbi.nlm.nih.gov/books/NBK525981/

Centers for Disease Control. (2018). Vaccines Indicated for Adults Based on Medical Indications Retrieved January 23, 2019, from https://www.cdc.gov/vaccines/schedules/hcp/imz/adult-conditions.html

Crawford‐Williams, F., March, S., Goodwin, B. C., Ralph, N., Galvao, D. A., Newton, R. U., ... & Dunn, J. (2018). Interventions for prostate cancer survivorship: A systematic review of reviews. Psycho‐Oncology, 27(10), 2339-2348.

Crestani, A., Esperto, F., Rossanese, M., Giannarini, G., Nicolai, N., & Ficarra, V. (2017). Andrological complications following retroperitoneal lymph node dissection for testicular cancer. Minerva Urologica e Nefrologica = The Italian Journal of Urology and Nephrology, 69(3), 209–219. https://doi.org/10.23736/S0393-2249.16.02789-2

Dimitropoulos, K., Karatzas, A., Papandreou, C., Daliani, D., Zachos, I., Pisters, L. L., & Tzortzis, V. (2016). Sexual dysfunction in testicular cancer patients subjected to post-chemotherapy retroperitoneal lymph node dissection: A focus beyond ejaculation disorders. Andrologia, 48(4), 425–430. https://doi.org/10.1111/and.12462

Ditto, A., Martinelli, F., Bogani, G., Fischetti, M., Di Donato, V., Lorusso, D., & Raspagliesi, F. (2015). Fertility-Sparing Surgery in Early-Stage Cervical Cancer Patients: Oncologic and Reproductive Outcomes. International Journal of Gynecological Cancer, 25(3), 493. https://doi.org/10.1097/IGC.0000000000000371

DoveMed (n.d.). Babesiosis. Retrieved January 23, 2019, from DoveMed website: http://www.dovemed.com/diseases-conditions/babesiosis/

Flechtner, H. H., Fischer, F., Albers, P., Hartmann, M., Siener, R., & German Testicular Cancer Study Group. (2016). Quality-of-life analysis of the German prospective multicentre trial of single-cycle adjuvant BEP versus retroperitoneal lymph node dissection in clinical stage I nonseminomatous germ cell tumours. European urology, 69(3), 518-525.

Fleischmann, I., Warschkow, R., Beutner, U., Marti, L., Schmied, B. M., & Steffen, T. (2017). Improved survival after retrieval of 12 or more regional lymph nodes in appendiceal cancer. European Journal of Surgical Oncology (EJSO), 43(10), 1876–1885. https://doi.org/10.1016/j.ejso.2017.06.015

Flores, R. M. (2016). The mesothelioma surgery shift. The Journal of Thoracic and Cardiovascular Surgery, 151(2), 485–486. https://doi.org/10.1016/j.jtcvs.2015.10.054

Gane, E. M., Steele, M. L., Janda, M., Ward, L. C., Reul-Hirche, H., Carter, J., … Hayes, S. C. (2018, January). The Prevalence, Incidence, and Quality-of-Life Impact of Lymphedema After Treatment for Vulvar or Vaginal Cancer [Text]. https://doi.org/info:doi/10.1097/01.REO.0000000000000102

Gil, S., Fernandez-Pineda, I., Rao, B., Neel, M. D., Baker, J. N., Wu, H., ... & Anghelescu, D. L. (2019). Role of Amputation in Improving Mobility, Pain Outcomes, and Emotional and Psychological Well-Being in Children With Metastatic Osteosarcoma. American Journal of Hospice and Palliative Medicine®, 36(2), 105-110.

Hashibe, M., Abdelaziz, S., Al-Temimi, M., Fraser, A., Boucher, K. M., Smith, K., … Stroup, A. (2016). Long-term health effects among testicular cancer survivors. Journal of Cancer Survivorship, 10(6), 1051–1057. https://doi.org/10.1007/s11764-016-0548-1

Hyde-Barrett, L. (2018, February 7). Mesothelioma Patients and Loved Ones Urged to Get Flu Shot. Retrieved February 20, 2019, from Mesothelioma Help Cancer Organization website: https://www.mesotheliomahelp.org/mesothelioma-patients-families-urged-get-flu-shot/

Karanicolas, P. J., Graham, D., Gönen, M., Strong, V. E., Brennan, M. F., & Coit, D. G. (2013). Quality of Life After Gastrectomy for Adenocarcinoma: A Prospective Cohort Study. Annals of Surgery, 257(6), 1039–1046. https://doi.org/10.1097/SLA.0b013e31828c4a19

Kaunitz, A. M., & Manson, J. E. (2015). Management of Menopausal Symptoms. Obstetrics and Gynecology, 126(4), 859–876. https://doi.org/10.1097/AOG.0000000000001058

Kawecki, A., & Krajewski, R. (2014). Follow-up in patients treated for head and neck cancer. Memo, 7(2), 87–91. https://doi.org/10.1007/s12254-014-0143-y

Kim, J. Y., Wie, G. A., Cho, Y. A., Kim, S. Y., Sohn, D. K., Kim, S. K., & Jun, M. D. (2018). Diet Modification Based on the Enhanced Recovery After Surgery Program (ERAS) in Patients Undergoing Laparoscopic Colorectal Resection. Clinical Nutrition Research, 7(4), 297–302. https://doi.org/10.7762/cnr.2018.7.4.297

Kobayashi, N., Kobayashi, K., Kikuchi, S., Goto, Y., Ichimura, H., Endo, K., & Sato, Y. (2017). Long-term pulmonary function after surgery for lung cancer. Interactive CardioVascular and Thoracic Surgery, 24(5), 727–732. https://doi.org/10.1093/icvts/ivw414

Kroon, B. B. R., Kroon, H. M., Noorda, E. M., Vrouenraets, B. C., Klaase, J. M., van Slooten, G. W., & Nieweg, O. E. (2016). Isolated Limb Perfusion for Melanoma. In K. R. Aigner & F. O. Stephens (Eds.), Induction Chemotherapy: Systemic and Locoregional (pp. 355–373). https://doi.org/10.1007/978-3-319-28773-7_25

Kroon, H. M., Huismans, A. M., Coventry, B. J., & Thompson, J. F. (2018). Isolated Limb Infusion for Recurrent and Locally Metastatic Limb Melanoma. In A. I. Riker (Ed.), Melanoma: A Modern Multidisciplinary Approach (pp. 451–465). https://doi.org/10.1007/978-3-319-78310-9_27

Kwekkeboom, D. J., & Krenning, E. P. (2016). Peptide Receptor Radionuclide Therapy in the Treatment of Neuroendocrine Tumors. Hematology/Oncology Clinics of North America, 30(1), 179–191. https://doi.org/10.1016/j.hoc.2015.09.009

Lam, D. L., Houssami, N., & Lee, J. M. (2017). Imaging surveillance after primary breast cancer treatment. American Journal of Roentgenology, 208(3), 676-686.

Lee, D. J., Tyson, M. D., & Chang, S. S. (2018). Conduit Urinary Diversion. The Urologic Clinics of North America, 45(1), 25–36. https://doi.org/10.1016/j.ucl.2017.09.006

Leone, G., & Pizzigallo, E. (2015). Bacterial Infections Following Splenectomy for Malignant and Nonmalignant Hematologic Diseases. Mediterranean Journal of Hematology and Infectious Diseases, 7(1). https://doi.org/10.4084/MJHID.2015.057

Macmillan Cancer Support. (n.d.). Living with a laryngectomy stoma - Information and support - Retrieved February 20, 2019, from https://www.macmillan.org.uk/information-and-support/larynx-cancer/treating/surgery/after-laryngectomy/laryngectomy-stoma.html

Martini, A., Villari, D., & Nicita, G. (2017). Long-term complications arising from bowel interposition in the urinary tract. International Journal of Surgery (London, England), 44, 278–280. https://doi.org/10.1016/j.ijsu.2017.07.030

Mattingly, M., Juran, R., Su, I., Ebinger, J., Daggy, J., & Tucker Edmonds, B. (2017). Patient knowledge of hysterectomy and pap screening after minimally invasive hysterectomy. Patient Education and Counseling, 100(1), 121–125. https://doi.org/10.1016/j.pec.2016.08.017

Mayo Clinic. (n.d). Pap smear: Still needed after hysterectomy?vRetrieved January 23, 2019, from Mayo Clinic website: https://www.mayoclinic.org/tests-procedures/pap-smear/expert-answers/pap-smear/faq-20058344

Memorial Sloan Kettering Cancer Center (n.d.).Treatment for Appendiceal Cancer. Retrieved February 14, 2019, from Memorial Sloan Kettering Cancer Center website: https://www.mskcc.org/cancer-care/types/appendiceal/treatment

Mioton, L. M., & Dumanian, G. A. (2018). Targeted muscle reinnervation and prosthetic rehabilitation after limb loss. Journal of surgical oncology, 118(5), 807-814.

Moyer, G. C., Grubb, R. L., & Johnson, F. E. (2012). Intestinal adenocarcinoma arising in urinary conduits. Oncology Reports, 27(2), 371–375. https://doi.org/10.3892/or.2011.1534

National Lymphedema Network. (n.d.). Position Papers. Retrieved March 4, 2019 from https://lymphnet.org/position-papers

Oldenburg, J. (2015). Hypogonadism and fertility issues following primary treatment for testicular cancer. Urologic Oncology: Seminars and Original Investigations, 33(9), 407–412. https://doi.org/10.1016/j.urolonc.2015.01.014

Oldenburg., J., Haugnes, H.S., Gillessen, S., Tandstad, T. (2016). Long-Term Complications After Testicular Cancer Treatment. Retrieved January 30, 2019, from Genitourinary Cancers Symposium website: https://gucasym.org/daily-news/long-term-complications-after-testicular-cancer-treatment

Rague, J. T., Varda, B. K., Wagner, A. A., & Lee, R. S. (2019). Delayed Return of Ejaculatory Function in Adolescent Males Treated With Retroperitoneal Lymph Node Dissection and Adjuvant Therapy for Paratesticular Rhabdomyosarcoma. Urology, 124, 254-256.

Romano, G., Agrusa, A., Galia, M., Di Buono, G., Chianetta, D., Sorce, V., ... & Gulotta, G. (2015). Whipple’s pancreaticoduodenectomy: Surgical technique and perioperative clinical outcomes in a single center. International Journal of Surgery, 21, S68-S71.

Rosenbaum, D. H., Cain, M. P., Kaefer, M., Meldrum, K. K., King, S. J., Misseri, R., & Rink, R. C. (2008). Ileal enterocystoplasty and B12 deficiency in pediatric patients. The Journal of urology, 179(4), 1544-1548.

Ruppert, L. M., Miskovitz, G., & Stubblefield, M. D. (2017). Cancer Survivorship. In N. D. Chiaravalloti & Y. Goverover (Eds.), Changes in the Brain: Impact on Daily Life (pp. 189–209). https://doi.org/10.1007/978-0-387-98188-8_9

Scorsetti, M., Leo, F., Trama, A., D’Angelillo, R., Serpico, D., Macerelli, M., … Garassino, M. C. (2016). Thymoma and thymic carcinomas. Critical Reviews in Oncology/Hematology, 99, 332–350. https://doi.org/10.1016/j.critrevonc.2016.01.012

Severi, S., Grassi, I., Nicolini, S., Sansovini, M., Bongiovanni, A., & Paganelli, G. (2017). Peptide receptor radionuclide therapy in the management of gastrointestinal neuroendocrine tumors: Efficacy profile, safety, and quality of life. OncoTargets and Therapy, 10, 551–557. https://doi.org/10.2147/OTT.S97584

Shaitelman, S. F., Cromwell, K. D., Rasmussen, J. C., Stout, N. L., Armer, J. M., Lasinski, B. B., & Cormier, J. N. (2015). Recent progress in the treatment and prevention of cancer-related lymphedema. CA: A Cancer Journal for Clinicians, 65(1), 55–81. https://doi.org/10.3322/caac.21253

Sherman, B., & Taylor, F. (2017). Adenocarcinoma in a Koff Urinary Ileal Diversion. Urology Case Reports, 13, 126–127. https://doi.org/10.1016/j.eucr.2017.03.029

Simone, M. D., & Vaira, M. (2013). Hyperthermic Isolated Limb Perfusion. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK6461/

Skovsted, S., Nielsen, K., & Blaak, J. (2017). Melanomas of the vulva and vagina. Pain, 3, 17-7.

Slouka, D., Kučera, R., Hošek, P., Gál, B., Trčka, O., Kostlivý, T., & Havel, D. (2018). Key problems of the quality of life of patients after total laryngectomy. Kontakt, 20(3), e230-e236.

Steenackers, N., Gesquiere, I., & Matthys, C. (2018, January). The relevance of dietary protein after bariatric surgery: What do we know? [Text]. https://doi.org/info:doi/10.1097/MCO.0000000000000437

Tang, C. G., & Sinclair, C. F. (2015). Voice Restoration After Total Laryngectomy. Otolaryngologic Clinics of North America, 48(4), 687–702. https://doi.org/10.1016/j.otc.2015.04.013

Tauro L.F., Roshan M., Hegde N., Bhat K.S., Vivek. (2006). Multidrug resistant malaria in splenectomized patients. Indian Journal of critical Care Medicine, 10 (4), 260-263.

Traa, M., Rutten, H., & den Oudsten, B. (2017). The Sexual Consequences of Cancer Surgery. In Y. Reisman & W. L. Gianotten (Eds.), Cancer, Intimacy and Sexuality: A Practical Approach (pp. 83–88). https://doi.org/10.1007/978-3-319-43193-2_12

Votanopoulos, K. I., Shen, P., Skardal, A., & Levine, E. A. (2018). Peritoneal Metastases from Appendiceal Cancer. Surgical Oncology Clinics of North America, 27(3), 551–561. https://doi.org/10.1016/j.soc.2018.02.007

Waks, A. G., & Winer, E. P. (2019). Breast Cancer Treatment: A Review. JAMA, 321(3), 288–300. https://doi.org/10.1001/jama.2018.19323

Wang, T. S., Opoku-Boateng, A., Roman, S. A., & Sosa, J. A. (2015). Prophylactic thyroidectomy: Who needs it, when, and why. Journal of Surgical Oncology, 111(1), 61–65. https://doi.org/10.1002/jso.23697

Wolf, A. S., & Flores, R. M. (2017). Special issue: Mesothelioma. Annals of Translational Medicine, 5(11). https://doi.org/10.21037/atm.2017.06.08

Yin, L., Fan, L., Tan, R., Yang, G., Jiang, F., Zhang, C., … Zhang, G. (2018). Bowel symptoms and self-care strategies of survivors in the process of restoration after low anterior resection of rectal cancer. BMC Surgery, 18(1), 35. https://doi.org/10.1186/s12893-018-0368-5

Yuen, T., & 阮端凝. (2017). Swallowing function after esophagectomy for esophageal cancer. Retrieved from http://hub.hku.hk/handle/10722/250812

Historical References

American Cancer Society. Cancer Treatment and Survivorship Facts & Figures 2014-2015. Atlanta: American Cancer Society; 2014.

Centers for Disease Control & Lance Armstrong Foundation (2004). A National Action Plan for Cancer Survivorship: Advancing Public Health Strategies, https://www.cdc.gov/cancer/survivorship/pdf/plan.pdf,

Centers for Disease Control and Prevention (CDC). (2004). Cancer survivorship--United States, 1971-2001. MMWR. Morbidity and Mortality Weekly Report, 53(24), 526.

Aapro, M., Bernard-Marty, C., Brain, E.G., Batist. G., Erdkamp, F., Krzemieniecki, K., Leonard, R., Lluch, A., Monfardini, S., Ryberg, M., Soubeyran, P., Wedding, U. (2011). Anthracycline cardiotoxicity in the elderly cancer patient: a SIOG expert position paper. Annals of Oncology, 22(2), 257-267.

Abou-Mourad, Y. R., Lau, B. C., Barnett, M. J., Forrest, D. L., Hogge, D. E., Nantel, S. H., ... & Sutherland, H. J. (2010). Long-term outcome after allo-SCT: close follow-up on a large cohort treated with myeloablative regimens. Bone Marrow Transplantation, 45(2), 295-302.

Aleman, B. M., van den Belt-Dusebout, A. W., Klokman, W. J., van’t Veer, M. B., Bartelink, H., & van Leeuwen, F. E. (2003). Long-term cause-specific mortality of patients treated for Hodgkin’s disease. Journal of Clinical Oncology, 21(18), 3431-3439.

Ahles, T. A., & Saykin, A. J. (2007). Candidate mechanisms for chemotherapy-induced cognitive changes. Nature Reviews Cancer, 7(3), 192-201.

Alfano, C. M., & Rowland, J. H. (2006). Recovery issues in cancer survivorship: a new challenge for supportive care. The Cancer Journal, 12(5), 432-443.

Baker, F., Denniston, M., Smith, T., & West, M. M. (2005). Adult cancer survivors: how are they faring? Cancer, 104(S11), 2565-2576.

Baker, K. S., Ness, K. K., Steinberger, J., Carter, A., Francisco, L., Burns, L. J., ... & Bhatia, S. (2007). Diabetes, hypertension, and cardiovascular events in survivors of hematopoietic cell transplantation: a report from the bone marrow transplantation survivor study. Blood, 109(4), 1765-1772.

Barry, E., Alvarez, J. A., Scully, R. E., Miller, T. L., & Lipshultz, S. E. (2007). Anthracycline-induced cardiotoxicity: course, pathophysiology, prevention and management. Expert Opinion on Pharmacotherapy, 8(8), 1039-1058.

Baum, M., Buzdar, A., Cuzick, J., Forbes, J., Houghton, J., Howell, A., & Sahmoud, T. (2003). Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early-stage breast cancer: results of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial efficacy and safety update analyses. Cancer, 98(9), 1802-1810.

Beasley, G. M., Caudle, A., Petersen, R. P., McMahon, N. S., Padussis, J., Mosca, P. J., ... & Andtbacka, R. H. (2009). A multi-institutional experience of isolated limb infusion: defining response and toxicity in the US. Journal of the American College of Surgeons, 208(5), 706-715.

Bhatia, S., Yasui, Y., Robison, L. L., Birch, J. M., Bogue, M. K., Diller, L., ... & Reaman, G. (2003). High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin’s disease: report from the Late Effects Study Group. Journal of Clinical Oncology, 21(23), 4386-4394.

Bibbins-Domingo, K., Grossman, D. C., Curry, S. J., Davidson, K. W., Epling, J. W., García, F. A., ... & Kurth, A. E. (2016). Screening for colorectal cancer: US Preventive Services Task Force recommendation statement. JAMA, 315(23), 2564-2575.

Bokemeyer, C., Berger, C. C., Kuczyk, M. A., & Schmoll, H. J. (1996). Evaluation of long-term toxicity after chemotherapy for testicular cancer. Journal of Clinical Oncology, 14(11), 2923-2932.

Bower, J. E. (2005). Prevalence and causes of fatigue after cancer treatment: the next generation of research. Journal of Clinical Oncology, 23(33), 8280-8282.

Braun, I. M., Greenberg, D. B., & Pirl, W. F. (2008). Evidenced-based report on the occurrence of fatigue in long-term cancer survivors. Journal of the National Comprehensive Cancer Network, 6(4), 347-354.

Brigden, M. L. (2001). Detection, education and management of the asplenic or hyposplenic patient. American Family Physician, 63(3), 499-506.

Buchegger, F., Antonescu, C., Delaloye, A. B., Helg, C., Kovacsovics, T., Kosinski, M., ... & Ketterer, N. (2006). Long-term complete responses after 131I-tositumomab therapy for relapsed or refractory indolent non-Hodgkin's lymphoma. British Journal of Cancer, 94(12), 1770-1776.

Burke, W. M., Orr, J., Leitao, M., Salom, E., Gehrig, P., Olawaiye, A. B., ... & SGO Clinical Practice Endometrial Cancer Working Group. (2014). Endometrial cancer: a review and current management strategies: part II. Gynecologic Oncology, 134(2), 393-402.

Buzdar, A. U. (2004). Data from the Arimidex, Tamoxifen, Alone or in Combination (ATAC) Trial. Clinical Cancer Research, 10(1), 355s-361s.

Camp-Sorrell, D. (2006). Cardiorespiratory Effects in Cancer Survivors: Cardiac and pulmonary toxicities may occur as late or long-term sequelae of cancer treatment. Cancer Nursing, 29(2), 55-59.

Cannon, G. W. (1997). Methotrexate pulmonary toxicity. Rheumatic Disease Clinics of North America, 23(4), 917-937.

Cardous‐Ubbink, M. C., Heinen, R. C., Langeveld, N. E., Bakker, P. J. M., Voute, P. A., Caron, H. N., & Van Leeuwen, F. E. (2004). Long‐term cause‐specific mortality among five‐year survivors of childhood cancer. Pediatric blood & cancer, 42(7), 563-573.

Carver, J. R., Shapiro, C. L., Ng, A., Jacobs, L., Schwartz, C., Virgo, K. S., ... & Vaughn, D. J. (2007). American Society of Clinical Oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac and pulmonary late effects. Journal of Clinical Oncology, 25(25), 3991-4008.

(2007). American Society of Clinical Oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac and pulmonary late effects. Journal of Clinical Oncology, 25(25), 3991-4008.

Chaudhary, U. B., & Haldas, J. R. (2003). Long-term complications of chemotherapy for germ cell tumours. Drugs, 63(15), 1565-1577.

Cohen, E. E. W., LaMonte, S. J., Erb, N. L., Beckman, K. L., Sadeghi, N., Hutcheson, K. A., Stubblefield, M. D., Abbott, D. M., Fisher, P. S., Stein, K. D., Lyman, G. H. and Pratt-Chapman, M. L. (2016), American Cancer Society Head and Neck Cancer Survivorship Care Guideline. CA: A Cancer Journal for Clinicians, 66: 203–239. doi:10.3322/caac.21343

Coletta, E. M. (2000). Care of the elderly patient with lower extremity amputation. The Journal of the American Board of Family Practice, 13(1), 23-34.

Demark-Wahnefried, W., Pinto, B. M., & Gritz, E. R. (2006). Promoting health and physical function among cancer survivors: potential for prevention and questions that remain. Journal of Clinical Oncology, 24(32), 5125-5131.

Deniz, K., O'Mahony, S., Ross, G., & Purushotham, A. (2003). Breast cancer in women after treatment for Hodgkin's disease. The Lancet Oncology, 4(4), 207-214.

Di Sabatino, A., Carsetti, R., & Corazza, G. R. (2011). Post-splenectomy and hyposplenic states. The Lancet, 378(9785), 86-97.

Doyle, J. J., Neugut, A. I., Jacobson, J. S., Grann, V. R., & Hershman, D. L. (2005). Chemotherapy and cardiotoxicity in older breast cancer patients: a population-based study. Journal of Clinical Oncology, 23(34), 8597-8605.

Earle, C. C. (2006). Failing to plan is planning to fail: improving the quality of care with survivorship care plans. Journal of Clinical Oncology, 24(32), 5112-5116.

Earle, C. C., & Neville, B. A. (2004). Under use of necessary care among cancer survivors. Cancer, 101(8), 1712-1719.

Elisaf, M. S., Bairaktari, E. T., Nicolaides, C., Kakaidi, B., Tzallas, C. S., Katsaraki, A., & Pavlidis, N. A. (2001). Effect of letrozole on the lipid profile in postmenopausal women with breast cancer. European Journal of Cancer, 37(12), 1510-1513.

Feuerstein, M. (2005). Cancer survivorship and work. Journal of occupational rehabilitation, 15(1), 1-2.

Fosså, S. D. (2003). Long-term sequelae after cancer therapy--survivorship after treatment for testicular cancer. Acta oncologica (Stockholm, Sweden), 43(2), 134-141.

Friedman, D. L., Rovo, A., Leisenring, W., Locasciulli, A., Flowers, M. E., Tichelli, A., ... & Socie, G. (2008). Increased risk of breast cancer among survivors of allogeneic hematopoietic cell transplantation: a report from the FHCRC and the EBMT-Late Effect Working Party. Blood, 111(2), 939-944.

Friedman, D. L., & Constine, L. S. (2006). Late effects of treatment for Hodgkin lymphoma. Journal of the National Comprehensive Cancer Network, 4(3), 249-257.

Ganz, P. A. (2006). Monitoring the physical health of cancer survivors: a survivorship-focused medical history. Journal of Clinical Oncology, 24(32), 5105-5111.

Ganz, P.A., and Erin E. Hahn. "Implementing a survivorship care plan for patients with breast cancer." Journal of Clinical Oncology 26.5 (2008): 759-767.

Ganz, P. A., Hussey, M. A., Moinpour, C. M., Unger, J. M., Hutchins, L. F., Dakhil, S. R., ... & Albain, K. S. (2008). Late cardiac effects of adjuvant chemotherapy in breast cancer survivors treated on Southwest Oncology Group protocol s8897. Journal of Clinical Oncology, 26(8), 1223-1230.

Ganz, P. A., Moinpour, C. M., Pauler, D. K., Kornblith, A. B., Gaynor, E. R., Balcerzak, S. P., ... & Fisher, R. I. (2003). Health status and quality of life in patients with early-stage Hodgkin’s disease treated on Southwest Oncology Group Study 9133. Journal of Clinical Oncology, 21(18), 3512-3519.

Garcia‐Rodriguez, M. J., Canales, M. A., Hernandez‐Maraver, D., & Hernandez‐Navarro, F. (2008). Late reactivation of resolved hepatitis B virus infection: An increasing complication post rituximab‐based regimens treatment?. American Journal of Hematology, 83(8), 673-675.

Gerharz, E. W., Turner, W. H., Kälble, T., & Woodhouse, C. R. J. (2003). Metabolic and functional consequences of urinary reconstruction with bowel. BJU International, 91(2), 143-149.

Gilbert, D. C., Van As, N. J., & Huddart, R. A. (2009). Reducing treatment toxicities in the management of good prognosis testicular germ cell tumors. Expert review of anticancer therapy, 9(2), 223-233.

Gilbert D et al. (2009). Reducing treatment toxicities in the management of good prognosis testicular cancer. Expert Review of Cancer Therapy 9(2): 223-233.

(2009). Reducing treatment toxicities in the management of good prognosis testicular germ cell tumors. Expert Reviews in Anticancer Therapy 9(2): 223-228.

Gospodarowicz, M. (2008). Testicular cancer patients: considerations in long-term follow-up. Hematology/Oncology Clinics of North America, 22(2), 245-255.

Greving, D. M., & Santacroce, S. J. (2005). Cardiovascular late effects. Journal of Pediatric Oncology Nursing, 22(1), 38-47.

Grunfeld, E. (2005). Cancer survivorship: a challenge for primary care physicians.

(2006). Looking beyond survival: how are we looking at survivorship? Journal of Clinical Oncology, 24(32), 5166-5169.

Guidry, J. J., Torrence, W., & Herbelin, S. (2005). Closing the divide: diverse populations and cancer survivorship. Cancer, 104(S11), 2577-2583.

Haddy, T. B., Adde, M. A., McCalla, J., Domanski, M. J., Datiles, M., Meehan, S. C., ... & Magrath, I. T. (1998). Late effects in long-term survivors of high-grade non-Hodgkin's lymphomas. Journal of Clinical Oncology, 16(6), 2070-2079.

Hakenberg, O. W., Compérat, E. M., Minhas, S., Necchi, A., Protzel, C., & Watkin, N. (2015). EAU guidelines on penile cancer: 2014 update. European Urology, 67(1), 142-150.

Hanson, K., & Kriescher, M. (2006). Cancer survivorship: State policy issues. National Conference of State Legislatures.

Hanson, K. (2006). State cancer survivorship policies. NCSL Legisbrief, 14(47), 1.

Hawkins, R.(2006). "Osteoporosis. Cancer survivors are at increased risk for osteoporosis, but how their management differs from that of the general population remains unclear. " American Journal of Nursing 106(3 Suppl): 78-82.

Haylock, P. J., Mitchell, S. A., Cox, T., Temple, S. V., & Curtiss, C. P. (2007).The cancer survivor's prescription for living. AJN The American Journal of Nursing, 107(4), 58-70.

Heidenreich, P. A., Schnittger, I., Strauss, H. W., Vagelos, R. H., Lee, B. K., Mariscal, C. S., ... & Hancock, S. L. (2006). Screening for coronary artery disease after mediastinal irradiation for Hodgkin's disease. Journal of Clinical Oncology, 25(1), 43-49.

Henderson, T. O., Whitton, J., Stovall, M., Mertens, A. C., Mitby, P., Friedman, D., ... & Robison, L. (2007). Secondary sarcomas in childhood cancer survivors: a report from the Childhood Cancer Survivor Study. Journal of the National Cancer Institute, 99(4), 300-308.

Hequet, O., Le, Q. H., Moullet, I., Pauli, E., Salles, G., Espinouse, D., ... & Bouafia, F. (2004). Subclinical late cardiomyopathy after doxorubicin therapy for lymphoma in adults. Journal of Clinical Oncology, 22(10), 1864-1871.

Herman, D. R., Ganz, P. A., Petersen, L., & Greendale, G. A. (2005). Obesity and cardiovascular risk factors in younger breast cancer survivors: The Cancer and Menopause Study (CAMS). Breast Cancer Research and Treatment, 93(1), 13-23.

Hodgson, D. C. (2008). Hodgkin lymphoma: the follow-up of long-term survivors. Hematology/Oncology Clinics of North America, 22(2), 233-244.

Hodgson, D. C., Grunfeld, E., Gunraj, N., & Del Giudice, L. (2010). A population‐based study of follow‐up care for Hodgkin lymphoma survivors. Cancer, 116(14), 3417-3425.

Hoffman, B., & Stovall, E. (2006). Survivorship perspectives and advocacy. Journal of Clinical Oncology, 24(32), 5154-5159.

Houldin, A., Curtiss, C. P., & Haylock, P. J. (2006). Executive summary: The state of the science on nursing approaches to managing late and long-term sequelae of cancer and cancer treatment. AJN The American Journal of Nursing, 106(3), 54-59.

(2006). The state of the science on nursing approaches to managing late and long-term sequelae of cancer and cancer treatment. Clinical Journal of Oncology Nursing, 10(3), 327.

Huddart, R. A., Norman, A., Moynihan, C., Horwich, A., Parker, C., Nicholls, E., & Dearnaley, D. P. (2005). Fertility, gonadal and sexual function in survivors of testicular cancer. British Journal of Cancer, 93(2), 200-207.

Hudson, M. M. (2005). A model for care across the cancer continuum. Cancer, 104(S11), 2638-2642.

National Research Council. (2005). From cancer patient to cancer survivor: lost in transition. Washington, DC: National Academies Press.

Jacene, H. A., Filice, R., Kasecamp, W., & Wahl, R. L. (2007). Comparison of 90Y-ibritumomab tiuxetan and 131I-tositumomab in clinical practice. Journal of Nuclear Medicine, 48(11), 1767-1776.

Jansen, C. E., Miaskowski, C., Dodd, M., Dowling, G., & Kramer, J. (2005). A metaanalysis of studies of the effects of cancer chemotherapy on various domains of cognitive function. Cancer, 104(10), 2222-2233.

Jensen, B. V. (2006, June). Cardiotoxic consequences of anthracycline-containing therapy in patients with breast cancer. In Seminars in oncology (Vol. 33, pp. 15-21). WB Saunders.

Johnson, S. A. (2006, June). Anthracycline-induced cardiotoxicity in adult hematologic malignancies. In Seminars in oncology (Vol. 33, pp. 22-27). WB Saunders.

Jones, K. W. (2000). A family physician's guide to monitoring methotrexate. American Family Physician, 62(7).

Josting, A., Wiedenmann, S., Franklin, J., May, M., Sieber, M., Wolf, J., ... & Diehl, V. (2003). Secondary myeloid leukemia and myelodysplastic syndromes in patients treated for Hodgkin’s disease: a report from the German Hodgkin’s Lymphoma Study Group. Journal of Clinical Oncology, 21(18), 3440-3446.

Kaufman, M. R., & Chang, S. S. (2007). Short-and long-term complications of therapy for testicular cancer. Urologic Clinics of North America, 34(2), 259-268.

Keefe, D. L. (2001, August). Anthracycline-induced cardiomyopathy. In Seminars in Oncology (Vol. 28, pp. 2-7). WB Saunders.

Khan, N. F., Carpenter, L., Watson, E., & Rose, P. W. (2010). Cancer screening and preventative care among long-term cancer survivors in the United Kingdom. British Journal of Cancer, 102(7), 1085-1090.

Koya, M. P., Simon, M. A., & Soloway, M. S. (2006). Complications of intravesical therapy for urothelial cancer of the bladder. The Journal of Urology, 175(6), 2004-2010.

Lackner, J. E., Märk, I., Schatzl, G., Marberger, M., & Kratzik, C. (2007). Hypogonadism and androgen deficiency symptoms in testicular cancer survivors. Urology, 69(4), 754-758.

Lamm, D. L., Van der Meijden, P. M., Morales, A. L. V. A., Brosman, S. A., Catalona, W. J., Herr, H. W., ... & Debruyne, F. M. (1992). Incidence and treatment of complications of bacillus Calmette-Guerin intravesical therapy in superficial bladder cancer. Journal of Urology 147(3), 596-600.

Lee, S. J., Schover, L. R., Partridge, A. H., Patrizio, P., Wallace, W. H., Hagerty, K., ... & Oktay, K. (2006). American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. Journal of Clinical Oncology, 24(18), 2917-2931.

Leigh, S. (2006). Cancer Survivorship: A First-Person Perspective: A nurse recounts her journey as patient, survivor, and advocate. AJN The American Journal of Nursing, 106, 12-14.

Leitao, M. M., & Chi, D. S. (2005). Fertility-sparing options for patients with gynecologic malignancies. The Oncologist, 10(8), 613-622.

Lockwood-Rayermann, S. (2006). Survivorship issues in ovarian cancer: a review. Oncology Nursing Forum, 33(3), 553-62.

Lowe, T., Bhatia, S., & Somlo, G. (2007). Second malignancies after allogeneic hematopoietic cell transplantation. Biology of Blood and Marrow Transplantation, 13(10), 1121-1134.

Lubow, M., Grzybowski, D. M., & Awad, H. (2008). Denilieukin diftitox vision loss is not posterior ischemic optic neuropathy. Leukemia & lymphoma, 49(2), 370-371.

Ludwig, H., Miguel, J. S., Dimopoulos, M. A., Palumbo, A., Sanz, R. G., Powles, R., ... & Romeril, K. (2014). International Myeloma Working Group recommendations for global myeloma care. Leukemia, 28(5), 981-992.

Majhail, N. S., Rizzo, J. D., Lee, S. J., Aljurf, M., Atsuta, Y., Bonfim, C., ... & Seber, A. (2012). Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation. Hematology/oncology and stem cell therapy, 5(1), 1-30.

Majhail, N. S., Ness, K. K., Burns, L. J., Sun, C. L., Carter, A., Francisco, L., ... & Baker, K. S. (2007). Late effects in survivors of Hodgkin and non-Hodgkin lymphoma treated with autologous hematopoietic cell transplantation: a report from the bone marrow transplant survivor study. Biology of Blood and Marrow Transplantation, 13(10), 1153-1159.

Malcolm, J. B., Bagrodia, A., Derweesh, I. H., Mehrazin, R., DiBlasio, C. J., Wake, R. W., ... & Patterson, A. L. (2009). Comparison of rates and risk factors for developing chronic renal insufficiency, proteinuria and metabolic acidosis after radical or partial nephrectomy. BJU international, 104(4), 476-481.

Manikantan, K., Khode, S., Dwivedi, R. C., Palav, R., Nutting, C. M., Rhys-Evans, P., ... & Kazi, R. (2009). Making sense of post-treatment surveillance in head and neck cancer: when and what of follow-up. Cancer treatment reviews, 35(8), 744-753.

McCaffrey J. A., & Scher, H. I. (1998). Interstitial pneumonitis following bicalutamide treatment for prostate cancer. The Journal of Urology, 160(1), 131.

Meadows, A. T. (2003). Pediatric cancer survivors: past history and future challenges. Current Problems in Cancer, 27(3), 112-126.

(2006). Pediatric cancer survivorship: research and clinical care. Journal of Clinical Oncology, 24(32), 5160-5165.

Meinardi, M. T., Gietema, J. A., Van Der Graaf, W. T. A., Van Veldhuisen, D. J., Runne, M. A., Sluiter, W. J., ... & Koops, H. S. (2000). Cardiovascular morbidity in long-term survivors of metastatic testicular cancer. Journal of Clinical Oncology, 18(8), 1725-1732.

Meinardi, M. T., Gietema, J. A., Van Veldhuisen, D. J., van der Graaf, W. T. A., de Vries, E. G. E., & Sleijfer, D. T. (2000). Long-term chemotherapy-related cardiovascular morbidity. Cancer Treatment Reviews, 26(6), 429-447.

Trotter, S. C., Sroa, N., Winkelmann, R. R., Olencki, T., & Bechtel, M. (2013). A global review of melanoma follow-up guidelines. Journal of Clinical & Aesthetic Dermatology, 6(9).

Michaud, L. B., & Goodin, S. (2006). Cancer-treatment-induced bone loss, part 1. American journal of Health-System Pharmacy, 63(5).

(2006). Cancer-treatment-induced bone loss, part 2. American Journal of Health System Pharmacy 63(6): 534-46.

Moleski, M. (2000). Neuropsychological, neuroanatomical, and neurophysiological consequences of CNS chemotherapy for acute lymphoblastic leukemia. Archives of Clinical Neuropsychology, 15(7), 603-630.

Mrozek, E., & Shapiro, C. L. (2005). Survivorship and complications of treatment in breast cancer. Clinical advances in Hematology & Oncology: H&O, 3(3), 211-22.

Mukamel, E. L. I. A. H. U., Konichezky, M., Engelstein, D., Cytron, S., Abramovici, A., & Servadio, C. (1990). Clinical and pathological findings in prostates following intravesical bacillus Calmette-Guerin instillations. The Journal of urology, 144(6), 1399-1400.

National Cancer Institute. (2013). Genetic Testing for Hereditary Cancer Syndromes. https://www.cancer.gov/about-cancer/causes-prevention/genetics/genetic-testing-fact-sheet

Nayfield, S. G., & Gorin, M. B. (1996). Tamoxifen-associated eye disease. A review. Journal of Clinical Oncology, 14(3), 1018-1026.

Nelson, M. B., & Meeske, K. (2005). Recognizing health risks in childhood cancer survivors. Journal of the American Academy of Nurse Practitioners, 17(3), 96-103.

Nieman, C. L., Kazer, R., Brannigan, R. E., Zoloth, L. S., Chase-Lansdale, P. L., Kinahan, K., ... & Woodruff, T. K. (2006). Cancer survivors and infertility: a review of a new problem and novel answers. Journal of Supportive Oncology 4(4), 171-178.

Noorda, E. M., van Kreij, R. H. J., Vrouenraets, B. C., Nieweg, O. E., Muller, M., Kroon, B. B. R., & Aaronson, N. K. (2007). The health-related quality of life of long-term survivors of melanoma treated with isolated limb perfusion. European Journal of Surgical Oncology (EJSO), 33(6), 776-782.

O'Dell, M., & Stubblefield, M. (2009). Cancer Rehabilitation: Principles and Practice. Demos Medical Publishing.

Oeffinger, K. C., Mertens, A. C., Sklar, C. A., Kawashima, T., Hudson, M. M., Meadows, A. T., ... & Schwartz, C. L. (2006). Chronic health conditions in adult survivors of childhood cancer. New England Journal of Medicine, 355(15), 1572-1582.

Oeffinger, K. C., & McCabe, M. S. (2006). Models for delivering survivorship care. Journal of Clinical Oncology, 24(32), 5117-5124.

Oktay, K. (2006). An individualized approach to fertility preservation in women with cancer. The Journal of Supportive Oncology, 4(4), 181-2, 184.

Ondrusova, M., Ondrus, D., Dusek, L., & Spanikova, B. (2008). Damage of hormonal function and bone metabolism in long-term survivors of testicular cancer. Neoplasma, 56(6), 473-479.

Pachler, J., & Wille‐Jørgensen, P. (2005). Quality of life after rectal resection for cancer, with or without permanent colostomy. The Cochrane Library.

Park, E. M., & Rosenstein, D. L. (2014). Living with Advanced Cancer Unmet Survivorship Needs. North Carolina Medical Journal, 75(4), 279-282.

Plana, J. C., Galderisi, M., Barac, A., Ewer, M. S., Ky, B., Scherrer-Crosbie, M., ... & Banchs, J. (2014). Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Journal of the American Society of Echocardiography, 27(9), 911-939.

Polomano, R. C., & Farrar, J. T. (2006). Pain and Neuropathy in Cancer Survivors: Surgery, radiation, and chemotherapy can cause pain; research could improve its detection and treatment. AJN The American Journal of Nursing, 106, 39-47.

Pozo, C. L., Morgan, M. A., & Gray, J. E. (2014). Survivorship issues for patients with lung cancer. Cancer Control, 21(1), 40-50.

Ram, R., Ben-Bassat, I., Shpilberg, O., Polliack, A., & Raanani, P. (2009). The late adverse events of rituximab therapy–rare but there!. Leukemia & lymphoma, 50(7), 1083-1095.

Rheingold, SR, Neugut, AI and AT Meadows (2003)."Secondary Cancers: Incidence, Risk Factors and Management" In Editors: Kufe, DW et.al. Cancer Medicine, 6 th ed., BC Decker, Ontario.

Riva, D., Giorgi, C., Nichelli, F., Bulgheroni, S., Massimino, M., Cefalo, G., ... & Pantaleoni, C. (2002). Intrathecal methotrexate affects cognitive function in children with medulloblastoma. Neurology, 59(1), 48-53.

Rizzo, J. D., Wingard, J. R., Tichelli, A., Lee, S. J., Van Lint, M. T., Burns, L. J., ... & Socié, G. (2006). Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, the Center for International Blood and Marrow Transplant Research, and the American Society of Blood and Marrow Transplantation. Biology of Blood and Marrow Transplantation, 12(2), 138-151.

Robison, L. L., Green, D. M., Hudson, M., Meadows, A. T., Mertens, A. C., Packer, R. J., ... & Zeltzer, L. K. (2005). Long‐term outcomes of adult survivors of childhood cancer. Cancer, 104(S11), 2557-2564.

Robson, M. E., Storm, C. D., Weitzel, J., Wollins, D. S., & Offit, K. (2010). American Society of Clinical Oncology policy statement update: genetic and genomic testing for cancer susceptibility. Journal of Clinical Oncology, 28(5), 893-901.

Runowicz, C. D., Leach, C. R., Henry, N. L., Henry, K. S., Mackey, H. T., Cowens-Alvarado, R. L., Cannady, R. S., Pratt-Chapman, M. L., Edge, S. B., Jacobs, L. A., Hurria, A., Marks, L. B., LaMonte, S. J., Warner, E., Lyman, G. H. and Ganz, P. A. (2016), American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline. CA: A Cancer Journal for Clinicians, 66: 43–73. doi:10.3322/caac.21319

Salani, R., Backes, F. J., Fung, M. F. K., Holschneider, C. H., Parker, L. P., Bristow, R. E., & Goff, B. A. (2011). Posttreatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncologists recommendations. American Journal of Obstetrics and Gynecology, 204(6), 466-478.

Sanki, A., Kroon, H. M., Kam, P. C., & Thompson, J. F. (2011). Isolated limb perfusion and isolated limb infusion for malignant lesions of the extremities. Current Problems in Surgery, 48(6), 371-430.

Sawaya, H., Sebag, I. A., Plana, J. C., Januzzi, J. L., Ky, B., Tan, T. C., ... & Martin, R. P. (2012). Assessment of Echocardiography and Biomarkers for the Extended Prediction of Cardiotoxicity in Patients Treated With Anthracyclines, Taxanes, and TrastuzumabClinical Perspective. Circulation: Cardiovascular Imaging, 5(5), 596-603.

Schaapveld, M., Aleman, B. M., van Eggermond, A. M., Janus, C. P., Krol, A. D., van der Maazen, R. W., ... & Van Imhoff, G. W. (2015). Second cancer risk up to 40 years after treatment for Hodgkin’s lymphoma. N Engl J Med, 2015(373), 2499-2511.

Schagen, S. B., Muller, M. J., Boogerd, W., Mellenbergh, G. J., & Van Dam, F. S. (2006). Change in cognitive function after chemotherapy: a prospective longitudinal study in breast cancer patients. Journal of the National Cancer Institute, 98(23), 1742-1745.

Schagen, S. B., & Van Dam, F. S. (2006). Does cognitive impairment after chemotherapy for breast cancer improve over time or does practice make perfect?. Journal of Clinical Oncology, 24(32), 5170-5171.

Maisonneuve, P., Botteri, E., & Lowenfels, A. B. (2008). Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps. Gastroenterology, 135(2), 710.

Sieniawski, M., Reineke, T., Josting, A., Nogova, L., Behringer, K., Halbsguth, T., ... & Engert, A. (2008). Assessment of male fertility in patients with Hodgkin's lymphoma treated in the German Hodgkin Study Group (GHSG) clinical trials. Annals of Oncology, 19(10), 1795-1801.

Simon, B., Lee, S. J., Partridge, A. H., & Runowicz, C. D. (2005). Preserving fertility after cancer. CA: A Cancer Journal for Clinicians, 55(4), 211-228.

Skolarus, T. A., Wolf, A., Erb, N. L., Brooks, D. D., Rivers, B. M., Underwood, W., ... & Wittmann, D. A. (2014). American Cancer Society prostate cancer survivorship care guidelines. CA: A Cancer Journal for Clinicians, 64(4), 225-249.

Sleijfer, S. (2001). Bleomycin-induced pneumonitis. Chest Journal, 120(2), 617-624.

Stapleton, S., & Blaney, S. (2006). New agents for intrathecal administration. Cancer investigation, 24(5), 528-534.

Steingart, R. M., Yadav, N., Manrique, C., Carver, J. R., & Liu, J. (2013, December). Cancer survivorship: cardiotoxic therapy in the adult cancer patient; cardiac outcomes with recommendations for patient management. In Seminars in Oncology (Vol. 40, No. 6, pp. 690-708). WB Saunders.

Steinherz, L. J., Steinherz, P. G., Tan, C. T., Heller, G., & Murphy, M. L. (1991). Cardiac toxicity 4 to 20 years after completing anthracycline therapy. JAMA, 266(12), 1672-1677.

Sugimura, H., & Yang, P. (2006). Long-term survivorship in lung cancer: a review. CHEST Journal, 129(4), 1088-1097.

Thomson, A. B., Critchley, H. O., Kelnar, C. J., & Wallace, W. H. B. (2002). Late reproductive sequelae following treatment of childhood cancer andoptions for fertility preservation. Best Practice & Research Clinical Endocrinology & Metabolism, 16(2), 311-334.

Tichelli, A., Passweg, J., Wójcik, D., Rovó, A., Harousseau, J. L., Masszi, T., ... & Sica, S. (2008). Late cardiovascular events after allogeneic hematopoietic stem cell transplantation: a retrospective multicenter study of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation. Haematologica, 93(8), 1203-1210.

Tichelli, A., Bucher, C., Rovó, A., Stussi, G., Stern, M., Paulussen, M., ... & Biedermann, B. (2007). Premature cardiovascular disease after allogeneic hematopoietic stem-cell transplantation. Blood, 110(9), 3463-3471.

Van Poppel, Hendrik, et al. "Penile cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up." Annals of Oncology 24.suppl 6 (2013): vi115-vi124.

Vardy, J., Rourke, S., & Tannock, I. F. (2007). Evaluation of cognitive function associated with chemotherapy: a review of published studies and recommendations for future research. Journal of Clinical Oncology, 25(17), 2455-2463.

Vaughn, D. J., & Meadows, A. T. (2002). Cancer survivorship research: the best is yet to come. Journal of clinical oncology, 20(4), 888-890.

Vaughn, D. J., Gignac, G. A., & Meadows, A. T. (2002). Long-term medical care of testicular cancer survivors. Annals of Internal Medicine, 136(6), 463-470.

Wallace, W. H., & Anderson, R. A. (2006). Cancer survivors and infertility: where do we go from here?. The Journal of Supportive Oncology, 4(4), 183-184.

Wong, P. W., Macris, N., DiFabrizio, L., & Seriff, N. S. (1998). Eosinophilic lung disease induced by bicalutamide: a case report and review of the medical literature. CHEST Journal, 113(2), 548-550.

Woodward, W. A., Strom, E. A., McNeese, M. D., Perkins, G. H., Outlaw, E. L., Hortobagyi, G. N., ... & Buchholz, T. A. (2003). Cardiovascular death and second non–breast cancer malignancy after postmastectomy radiation and doxorubicin-based chemotherapy. International Journal of Radiation Oncology* Biology* Physics, 57(2), 327-335.

Yahalom, J., & Portlock, C. S. (2011). Long-term cardiac and pulmonary complications of cancer therapy. Heart Failure Clinics, 7(3), 403-411.

Yarbro, C. H., Wujcik, D., & Gobel, B. H. (2010). Cancer nursing: Principles and practice. Boston: Jones & Bartlett Publishers.

Yabroff, K. R., Lawrence, W. F., Clauser, S., Davis, W. W., & Brown, M. L. (2004). Burden of illness in cancer survivors: findings from a population-based national sample. Journal of the National Cancer Institute, 96(17), 1322-1330.

Younes, A., Bartlett, N. L., Leonard, J. P., Kennedy, D. A., Lynch, C. M., Sievers, E. L., & Forero-Torres, A. (2010). Brentuximab vedotin (SGN-35) for relapsed CD30-positive lymphomas. New England Journal of Medicine, 363(19), 1812-1821.

Zoltick, B. H., Jacobs, L. A., & Vaughn, D. J. (2005, September). Cardiovascular risk in testicular cancer survivors treated with chemotherapy: incidence, significance, and practice implications. In Oncology Nursing Forum (Vol. 32, No. 5).

References

Medical Oncology References

Radiation Therapy References

Surgery References

Other Content References

Historical References